Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:

Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)

NCT03180619 ·Status: COMPLETED ·Phase: PHASE2

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

NCT02932150 ·Status: RECRUITING ·Phase: PHASE2

A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)

NCT00507507 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed

NCT02979613 ·Status: COMPLETED ·Phase: PHASE3

Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance

NCT03566030 ·Status: UNKNOWN

TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)

NCT03798119 ·Status: UNKNOWN ·Phase: PHASE4

The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury.

NCT04674423 ·Status: RECRUITING ·Phase: PHASE4

TAF to Prevent HBV Reactivation in Cancer Patients

NCT04619082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Tenofovir Alafenamide in HBV Related Decompensated Liver

NCT04683341 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides

NCT04201808 ·Status: UNKNOWN ·Phase: PHASE4

Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea

NCT03559790 ·Status: UNKNOWN

Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)

NCT05177926 ·Status: UNKNOWN ·Phase: PHASE4

Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines

NCT03753074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)

NCT02836249 ·Status: COMPLETED ·Phase: PHASE3

Use of TDF in Patients With Inactive Chronic Hepatitis B Infection

NCT02600117 ·Status: COMPLETED ·Phase: PHASE3

Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B Virus

NCT04065230 ·Status: UNKNOWN

A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)

NCT01727271 ·Status: WITHDRAWN ·Phase: PHASE4

TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

NCT05195450 ·Status: RECRUITING ·Phase: NA

Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B

NCT06896630 ·Status: NOT_YET_RECRUITING

Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil

NCT00307489 ·Status: COMPLETED ·Phase: PHASE2

Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B

NCT05583006 ·Status: RECRUITING

A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection

NCT00736190 ·Status: COMPLETED ·Phase: PHASE4

Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B

NCT04629976 ·Status: COMPLETED ·Phase: PHASE1

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

NCT03933384 ·Status: RECRUITING ·Phase: PHASE4

A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B

NCT00116805 ·Status: COMPLETED ·Phase: PHASE3